← Open Payments lookup

TIMOTHY PELLEGRIN: Open Payments

NPI 1134160815 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$64,847 in 185 payments from 17 companies in 2025. Trend: 2023 $46,532 · 2024 $23,015 · 2025 $64,847

Speaker / faculty: $53,905Travel & lodging: $5,289Food & beverage: $3,504Consulting: $2,040Education: $109
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)98$58,406
ABBVIE INC.18$4,947
Alkermes, Inc.17$230
Teva Pharmaceuticals USA, Inc.6$222
Janssen Pharmaceuticals, Inc4$198
Axsome Therapeutics, Inc.7$152
Vanda Pharmaceuticals Inc.8$142
Corium, LLC7$121
Otsuka America Pharmaceutical, Inc.3$81
Collegium Pharmaceutical, Inc.4$73

Products named: CAPLYTA, VRAYLAR, ARISTADA, SPRAVATO, Auvelity, FANAPT, Azstarys, REXULTI.

Industry payments across LA — which companies pay providers there.